KNOWLEDGE AND PRESCRIBING PRACTICE OF AMUBULATORY CARE PHYSICIANS ABOUT DISTINCT ANTIBIOTICSTOWARDS TRIVIALRESPIRATORY TRACT INFECTED PATIENTS: STRATEGIES FOR OPTIMAL OUTCOMES AND MINIMIZED RESISTANCE
DOI:
https://doi.org/10.22270/ajprd.v6i6.449Keywords:
Prescribing Behavior, Trivial Respiratory Tract Infections (RTI), Broad Spectrum Antibiotics,Ambulatory Care Physicians, Cost Effective PrescriptionAbstract
According to World Health Organization (WHO), respiratory tract infections kill 2.6 million children every year worldwide so, it is recognized as the leading cause of morbidity and mortality. Respiratory tract diseases are quite prevalent & more dangerous to the people with weak immune system function. The study was carried out for a period of 90 to 100 days in Rajiv Gandhi Institute of Medical Sciences (RIMS), Kadapa. Antibiotics are prescribed based on symptoms and laboratory investigations. It is a single centered, prospective observational study. Subjects of both genders who indicated with any one antibiotic or its combination are taken in our study and patients who had co morbid pathological conditions also included. Pediatrics, pregnant women and surgical cases were excluded from the study.60 patients (Ambulatory patients) were collected. 36 were male and 24 were female. 20 patients were found to be Literates and 40 patients were Illiterates. 38 patients belong to Lower class, 17 patients belong to Middle class and 5 patients belong to Upper class. 9 patients belong to 15-30 years of age group, 21 patients belong to 31-45 years of age group, 16 patients belong to 46-60 years of age. Ceftriaxone is prescribed in 24 patients, Azithromycin is prescribed in 17 patients, Levofloxacin is prescribed in 7 patients, Ceftriaxone + Augmentin is prescribed in 12 patients.Drug utilization studies used to analyze the different aspects of the use of drugs and to implement ways of improving therapeutic quality. In the present study, pneumonia diagnosed patients (12 patients) received antibiotic combination regimen, while other common respiratory disease patients (48 patients) received single antibiotic during treatment. All the prescribed antibiotics belong to broad spectrums that are effective against most of causative organisms such as Streptococcus, Staphylococcus, Mycoplasma, Klebsiella, Hemophilus etc. In our study, it was also found that, physicians prescribed correct drug in correct dose at correct time through right route of administration for right duration of treatment, it clearly implies that most of the prescriptions found to be Rational.
Downloads
References
2. Gauchan P, Lekhak B, Sherchand JB., The Prevalence of lower respiratory tract infection in adults visiting Tribhuvan University Teaching Hospital. Journal of Institute of Medicine, 2006, 28(2): 10-14.
3. Zwart, S, Ruijs G J, Sachs A P Schellekens J F and De Melke R A: Potentially virulent strains and high colony counts of group A streptococci in pharyngitis patients, Journal of Antimicrobial Chemotherapy, 2001, 4(9): 689-91.
4. Kumari, H.B.V., Nagarathna. S, and Chandramuki, A.: Antimicrobial resistance pattern among aerobic gram negative bacilli of lower respiratory tract specimens of intensive care unit patients, Indian. J. Chest. Dis. Allied. Sciences, 2007, 4(3): 19-22.
5. Hirshberg B, Sklair-Levi M, Nir-Paz R, Ben-SiraL, Krivoruk V, Kramer MR, "Factors predicting mortality of patients with lung abscess". American Chest Journal, 1999, 15(3): 746-50.
6. American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA), adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Medicine, 2005, 17(1):388-416.
7. Melsen WG, Rovers MM, Groenwold RHet al, Attributable mortality of pharyngitis: A meta-analysis of individual patient data from randomised prevention studies. Lancet
Infect Disease, 2013, 1(3):665-71.
8. Sopena N, Sabria M; Neunos Study Group. Multicenter study of pleural effusion in non-ICU patients, journal of Chest, medicine, 2005, 12(7):213-19.
9. Chalmers JD, Rother C, Salih W, Ewig S,chronic bronchitisdoes not accurately identify potentially resistant pathogens: A systematic review and meta-analysis, Clinical Infectious Disease, 2014, 5(8):330-9.
10. A Review of Ceftriaxone for the Treatment of Respiratory tract Infections, Clinical Medicine and Therapeutics, 2009, 6(12): 120-4.
11. A Review of Augmentin for the Treatment of Respiratory tract Infections, Clinical Medicine and Therapeutics, 2009, 6(12): 205-14.
12. A Review of Levofloxacin for the Treatment of Respiratory tract Infections, Clinical Medicine and Therapeutics, 2009, 6(12): 38-46.
13. A Review of Azithromycin for the Treatment of Respiratory tract Infections, Clinical Medicine and Therapeutics, 2009, 6(12): 62-7.
14. Guyatt GH, Oxman AD, Vist GEet al, GRADE: An emerging consensus on rating quality of evidence and strength of recommendations, British Medical Journal, 2008, 33(6):924-6.
15. EsperattiM , Ferrer M, Giunta Vet al, Validation of predictors of adverse outcomes in respiratory tract infections in ICU, Critical Care Medicine, 2013 4(1):2151-61
16. Dudeck MA, Horan TC, Peterson KDet al, National Healthcare Safety Network (NHSN) report, device-associated module, American Journal of Infectious Control, 2011, 3(9):349-67.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.